BioTelemetry, Inc.
(NASDAQ : BEAT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-1.79%93.790.6%$584.73m
ABTAbbott Laboratories
-1.95%70.770.8%$486.79m
ISRGIntuitive Surgical, Inc.
-3.99%491.812.4%$394.20m
TMOThermo Fisher Scientific Inc.
-2.96%234.201.0%$390.29m
BAXBaxter International Inc.
-1.85%65.711.7%$299.35m
BSXBoston Scientific Corporation
-3.19%35.801.1%$296.81m
ALGNAlign Technology, Inc.
-0.76%215.576.3%$291.36m
DXCMDexCom, Inc.
-1.92%120.668.5%$277.75m
BDXBecton, Dickinson and Company
-2.27%231.521.1%$262.79m
SYKStryker Corporation
-3.64%166.571.3%$228.79m
EWEdwards Lifesciences Corporation
-2.34%160.101.2%$225.73m
ABMDABIOMED, Inc.
-1.10%316.193.3%$200.61m
ZBHZimmer Biomet Holdings, Inc.
-3.01%108.981.7%$125.91m
WATWaters Corporation
-1.14%189.023.5%$107.33m
XRAYDENTSPLY International Inc.
-1.99%36.973.1%$105.68m

Company Profile

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The company also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through operates through three segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.